Nowadays, several FDA-approved theranostic pairs, such as [68Ga]DOTATATE and [177Lu]DOTATATE for neuroendocrine tumors, are used in clinical nuclear medicine practice [13,14]. However, FDA-approved theranostic pairs for breast cancer are currently limited. Thus, the invention of nuclear imaging ...